• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [23537 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Sunitinib for the management of renal cell carcinoma
2006     Quality Improvement Scotland (NHS QIS ) Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents (review)
2006     National Institute for Health and Care Excellence (NICE) High dose rate brachytherapy for carcinoma of the cervix. NICE interventional procedures guidance 160
2006     Finnish Office for Health Care Technology Assessment (Finohta) The impact of an extension of breast cancer screening: update of Finohta's report 16/2000
2006     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) The effect of delaying adjuvant radiotherapy without chemotherapy on the outcome of conserving treatment on breast cancer (revised edition)
2006     National Institute for Health and Care Excellence (NICE) Percutaneous endoscopic colostomy. NICE interventional procedures guidance 161
2006     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Metastatic melanoma vaccines
2006     Alberta Heritage Foundation for Medical Research (AHFMR) Using HTA to identify research gaps: a pilot study
2006     National Institute for Health and Care Excellence (NICE) Stent-graft placement in abdominal aortic aneurysm. NICE interventional procedures guidance 163
2006     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Vaccines for avian influenza
2006     Institute for Clinical Systems Improvement (ICSI) Omega-3 fatty acids for coronary artery disease
2006     Adelaide Health Technology Assessment (AHTA) Remote monitoring systems for implantable cardiac devices (cardioverter defibrillators andpacemakers)
2006     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Familial hypercholesterolemia: evaluation of genetic screening by DNA microarrays]
2006     National Institute for Health and Care Excellence (NICE) Photorefractive (laser) surgery for the correction of refractive errors. NICE interventional procedures guidance 164
2006     National Institute for Health and Care Excellence (NICE) Laparoscopic surgery for colorectal cancer. NICE technology appraisal guidance 105
2006     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Vaccine for herpes simplex
2006     New Zealand Health Technology Assessment (NZHTA) Review of the National Cervical Screening programme. Chapter 5: interim operational policy and quality standards 2000. Technical brief.
2006     Institute for Clinical Systems Improvement (ICSI) Carotid, vertebral and intracranial artery angioplasty and stenting
2006     Adelaide Health Technology Assessment (AHTA) Nurse-led telephone program to monitor heart failure patients after hospital discharge
2006     National Institute for Health and Care Excellence (NICE) Endometrial cryotherapy for menorrhagia. NICE interventional procedures guidance 157
2006     National Institute for Health and Care Excellence (NICE) Etanercept and efalizumab for the treatment of adults with psoriasis. NICE technology appraisal guidance 103
2006     NIHR Health Technology Assessment programme Computed tomography screening for heart disease
2006     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Selegiline transdermal patch
2006     New Zealand Health Technology Assessment (NZHTA) The effectiveness of interventions to promote fruit and vegetable intake in school-aged children: a tech brief
2006     Adelaide Health Technology Assessment (AHTA) Program for the treatment of locally advanced prostate cancer
2006     National Institute for Health and Care Excellence (NICE) Photodynamic therapy for non-melanoma skin tumours (including premalignant and primary non-metastatic skin lesions). NICE interventional procedures guidance 155
2006     National Institute for Health and Care Excellence (NICE) Docetaxel for the treatment of hormone-refractory metastatic prostate cancer. NICE technology appraisal guidance 101
2006     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Radiofrequency ablation in the treatment of kidney cancer
2006     Adelaide Health Technology Assessment (AHTA) Computed tomography coronary angiography for the detection of coronary artery disease
2006     National Institute for Health and Care Excellence (NICE) Image-guided vacuum-assisted excision biopsy of benign breast lesions. NICE interventional procedures guidance 156
2006     National Institute for Health and Care Excellence (NICE) Capecitabine and oxaliplatin in the adjuvant treatment of stage III (Dukes' C) colon cancer. NICE technology appraisal guidance 100
2006     The Netherlands Organisation for Health Research and Development (ZonMw) [A randomised cost-effectiveness study on the surgical versus conservative treatment of sciatica]
2006     HAYES, Inc. Active specific immunotherapy with therapeutic melanoma vaccines
2006     Adelaide Health Technology Assessment (AHTA) Screening for hypertrophic cardiomyopathy in individuals at high-risk of sudden cardiac death
2006     National Institute for Health and Care Excellence (NICE) Laparoscopic partial nephrectomy. NICE interventional procedures guidance 151
2006     National Institute for Health and Care Excellence (NICE) Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic hepatitis B. NICE technology appraisal guidance 96
2006     The Netherlands Organisation for Health Research and Development (ZonMw) [Cost-effectiveness of follow-up of patients with superficial bladder cancer]
2006     HAYES, Inc. Automated percutaneous lumbar discectomy
2006     Adelaide Health Technology Assessment (AHTA) Telemedicine for the implementation of stroke therapy for patients in rural and remote areas
2006     National Institute for Health and Care Excellence (NICE) Foker technique for long-gap oesophageal atresia. NICE interventional procedures guidance 153
2006     The Netherlands Organisation for Health Research and Development (ZonMw) [Randomized trial on the effects of a psychogeriatric diagnostic day hospital]
2006     NIHR Health Technology Assessment programme A systematic review of the clinical effectiveness, safety, tolerability and cost effectiveness of efalizumab and etanercept within their licensed indications for the treatment of psoriasis. - NICE Technology Assessment Report
2006     The Swedish Council on Health Technology Assessment (SBU) Bilateral cochlear implantation (CI) in children: early assessment briefs (Alert)
2006     HAYES, Inc. Electrical stimulation for the treatment of oropharyngeal dysphagia
2006     Adelaide Health Technology Assessment (AHTA) Rapid point-of-care for the detection of Chlamydia in individuals at risk of trachoma
2006     The Swedish Council on Health Technology Assessment (SBU) Therapeutic hypothermia after resuscitation from cardiac arrest: early assessment briefs (Alert)
2006     HAYES, Inc. Endoluminal radiofrequency ablation for varicose veins of the leg
2006     Adelaide Health Technology Assessment (AHTA) Autologous bone marrow transplant for the treatment of patients who have experienced heart failure
2006     HAYES, Inc. Etanercept for treatment of psoriasis and psoriatic arthritis
2006     Adelaide Health Technology Assessment (AHTA) Implantable Miniature Telescope for the treatment of age-related macular degeneration
2006     Blue Cross Blue Shield Association (BCBS) Special report: measuring and reporting pain outcomes in randomized controlled trials
2006     University of York Guidance on the conduct of narrative synthesis in systematic reviews
2006     HAYES, Inc. Extracorporeal membrane oxygenation for respiratory failure (children and adults)
2006     Adelaide Health Technology Assessment (AHTA) Vertebral assessment with DEXA: Screening for vertebral fracture during risk assessment for osteoporosis
2006     Blue Cross Blue Shield Association (BCBS) Special report: recombinant activated factor VII for uncontrolled bleeding in non-hemophiliac patients
2006     HAYES, Inc. Human papillomavirus vaccines for prevention of cervical cancer
2006     Adelaide Health Technology Assessment (AHTA) Genetic testing for long QT syndrome; horizon scanning prioritising summary - volume 13
2006     Blue Cross Blue Shield Association (BCBS) Off-label uses of bevacizumab: renal cell carcinoma and other miscellaneous non-colorectal cancer indications
2006     VA Technology Assessment Program (VATAP) Wait times for primary hip and knee replacement surgery
2006     HAYES, Inc. Hysteroscopic tubal occlusion for permanent contraception
2006     Adelaide Health Technology Assessment (AHTA) Program for the distribution of free nicotine patches: a smoking cessation program
2006     Blue Cross Blue Shield Association (BCBS) Off-label uses of Bevacizumab: breast and lung cancer indications
2006     VA Technology Assessment Program (VATAP) Benzocaine-associated methemoglobinemia in dental patients
2006     HAYES, Inc. Intraperitoneal hyperthermic chemotherapy for abdominopelvic cancers
2006     Adelaide Health Technology Assessment (AHTA) Proton Beam Therapy for the treatment of cancer
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Wavefront analysis in refractive surgery
2006     HAYES, Inc. Intravenous immunoglobulin for children with HIV infection
2006     Adelaide Health Technology Assessment (AHTA) Foramen Ovale Closure devices for the treatment of migraine
2006     Health Council of the Netherlands Gezondheidsraad (GR) BaP and PAH from coal-derived sources: health-based calculated occupational cancer risk values of benzo[a]pyrene and unsubstituted non-heterocyclic polycyclic aromatic hydrocarbons from coal-derived sources
2006     HAYES, Inc. Laser prostatectomy for benign prostatic hyperplasia
2006     Adelaide Health Technology Assessment (AHTA) Primer and probe set for the diagnosis of avian influenza
2006     NIHR Health Technology Assessment programme Developing an instrument to measure social inclusion - a literature review and consensus exercise (phase 1)
2006     HAYES, Inc. Lymphatic mapping for identification of sentinel nodes in breast cancer
2006     Adelaide Health Technology Assessment (AHTA) Dose verification system for the measurement of radiation dose in patients undergoing radiotherapy for breast and prostate cancer
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Tactile devices in audiology
2006     Technology Assessment Unit of the McGill University Health Centre (MUHC) Should the McGill University Health Centre use safety devices to reduce needlestick injuries associated with intravascular infusions?
2006     HAYES, Inc. Pancreas-after-kidney (PAK) transplantation in diabetic patients
2006     Adelaide Health Technology Assessment (AHTA) Magnetic resonance spectroscopy for the diagnosis of suspected breast malignancies
2006     Basque Office for Health Technology Assessment (OSTEBA) [Study of satisfaction and detection factors in the in-patient's care, that the deceased's family consider important at the final phase of life]
2006     NIHR Health Technology Assessment programme Development of a social inclusion index to capture subjective and objective domains (phase 1)
2006     Technology Assessment Unit of the McGill University Health Centre (MUHC) The use of mitoxantrone in the treatment of patients with multiple sclerosis: report update
2006     HAYES, Inc. Plasma exchange for multiple sclerosis
2006     Adelaide Health Technology Assessment (AHTA) Nicotine metabolite ratio test as a predictor of smoking cessation
2006     NIHR Health Technology Assessment programme A study to establish the feasibility of a trial that would investigate the clinical and cost-effectiveness of stopping bisphosphonate treatment after 5 years in post-menopausal women with osteoporosis who have already had a fracture
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Device for Intervertebral Assisted Motion (DIAM) in spine instability
2006     Technology Assessment Unit of the McGill University Health Centre (MUHC) Testing for HER2 positive breast cancer: a cost-effectiveness analysis
2006     HAYES, Inc. Simultaneous pancreas-kidney (SPK) transplantation in diabetic patients
2006     Adelaide Health Technology Assessment (AHTA) MR and transient elastography for the non-invasive assessment of liver fibrosis
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Transcutaneous electrical nerve stimulation (TENS-PENS) for back pain
2006     HAYES, Inc. Total hip resurfacing arthroplasty
2006     Adelaide Health Technology Assessment (AHTA) Pre-hospital administration of antibiotics by paramedics for suspected cases of meningococcal disease
2006     Medical Services Advisory Committee (MSAC) Implantable cardioverter defibrillators for prevention of sudden cardiac death
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of alpha-glucosidase in Pompe disease
2006     Agency for Healthcare Research and Quality (AHRQ) Management of small cell lung cancer
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Rituximab for the treatment of rheumatoid arthritis
2006     Health Council of the Netherlands Gezondheidsraad (GR) Electromagnetic fields: annual update
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Percutaneous hallux valgus surgical correction
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Androgen deprivation treatment (hormonal therapy) for the management of prostate cancer
2006     Adelaide Health Technology Assessment (AHTA) Pillar procedure for the treatment of obstructive sleep apnoea and snoring
2006     HAYES, Inc. Proton beam therapy for thoracic and abdominal organs